United States Cellular Allografts Market Report 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "US Market Report for Cellular Allografts 2017 - MedCore" report to their offering.

The cellular allograft market is segmented into usage for the cervical and lumbar regions of the spine. The cellular allograft market is the fastest growing within the overall bone graft market. By far, the largest market segment was for lumbar usage, with the remainder going to cervical. Both segments are growing rapidly, which will continue over the forecast period. Contributing to the larger market share of the lumbar segment is that much more graft material is required for lumbar usage. Use of stem cell grafts outside of the spine will also see growth; this should bring an even greater market potential for stem cell grafts.

The high average selling price (ASP) of cellular allografts has provided incentives for new players to enter the market. The synergies between the bone graft substitute materials such as allografts and DBMs provide a platform for companies that operate within those markets to pursue growth by expanding into cellular allograft market.

Key Topics Covered:

1. Research Methodology

2. Disease Overview

2.1 Basic Anatomy

2.1.1 Osteology And Musculoskeletal System

2.2 Disease Pathology And Disorders

2.2.1 General Diagnostic

2.2.2 Osteoporosis

2.2.3 Osteoarthritis

2.2.4 Indication For Bone Graft Procedure

2.2.5 Indication For Cartilage Repair

2.2.6 Degenerative Disc Disease

2.3 Patient Demographics

2.3.1 General Statistics

3. Product Assessment

3.1 Product Portfolios

3.1.1 Cellular Allografts

3.2 Clinical Trials

3.2.1 Cellular Allografts

4. Cellular Allograft Market

4.1 Introduction

4.1.1 Lineage

4.1.1.1 Human Embryonic Stem Cells (Hesc)

4.1.1.2 Mesenchymal Stem Cells (Msc)

4.1.2 Other Therapeutic Applications

4.2 Market Overview

4.3 Market Analysis And Forecast

4.3.1 Total Cellular Allograft Market

4.3.1.1 Cervical Spine Stem Cell Market

4.3.1.2 Lumbar Spine Stem Cell Market

4.4 Drivers And Limiters

4.5 Competitive Market Share Analysis

Companies Mentioned

- Medtronic

- Genzyme

- DePuy Synthes

- Anika Therapeutics

- Ferring Pharmaceuticals

- Stryker

- NuVasive

- Bioventus

- Zimmer Biomet

- Integra LifeSciences

- RTI Surg

For more information about this report visit http://www.researchandmarkets.com/research/drz73g/us_market_report

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Surgical Procedures

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Surgical Procedures